Two New Tests To Determine The Future Of Patients With Diseased Kidneys.
Researchers have come up with two further tests that seem better able to foretell which patients with long-lived kidney disease are more likely to progress to kidney failure and death. This could help streamline care, getting those patients who straits it most the care they need, while perhaps sparing other patients unnecessary interventions effect. "The creative markers provide us with an opportunity to address kidney disease prior to its extreme stage," said Dr Ernesto P Molmenti, vice chairman of surgery and commander of the transplant program at the North Shore-Long Island Jewish Health System in Manhasset, NY - "Such antiquated treatment could provide for increased survival, as well as enhanced quality of life".
And "The predominating problem right now is the tests we use currently just are not very good at identifying people's progressing to either more advanced kidney blight or end-stage kidney disease, so this has big implications in trying to determine who will progress," said Dr Troy Plumb, interim leading of nephrology at the University of Nebraska Medical Center in Omaha testmedplus.com. But "there are current to have to be validated clinical trials" before these new tests are introduced into clinical practice.
Both studies will appear in the April 20 end of the Journal of the American Medical Association, but were released Monday to co-occur with presentations at the World Congress of Nephrology, in Vancouver. Some 23 million populace in the United States have chronic kidney disease, which can often progress to kidney loser (making dialysis or a transplant necessary), and even death. But experts have no really compelling way to predict who will progress to more serious disease or when.
Right now, kidney function, or glomerular filtration speed (GFR), is based on measuring blood levels of creatinine, a waste result that is normally removed from the body by the kidneys. The first set of study authors, from the San Francisco VA Medical Center, added two other measurements to the mix: GFR clockwork by cystatin C, a protein also eliminated from the body by the kidneys; and albuminuria, or too much protein in the urine.
